MannKind Corporation

MannKind Corporation focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. Its lead product candidate, AFREZZA(R) , is in late stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. AFREZZA® (pronounced uh-FREZZ-uh), approved in 2014 by the U.S. Food and Drug Administration is a rapid-acting inhaled insulin therapy indicated to improve glycemic control in adults with diabetes. Taken at the start of a meal using a specially designed inhaler, Afrezza dissolves rapidly upon inhalation to the deep lung and delivers insulin quickly to the bloodstream. Peak insulin levels are achieved within 12 to 15 minutes of use and help to control post-meal blood sugar spikes that affect HbA1C levels. AFREZZA utilizes our proprietary Technosphere® formulation technology , which is based on a class of organic molecules that are designed to self-assemble into small particles onto which drug molecules can be loaded. We believe Technosphere represents a versatile drug delivery platform that may allow pulmonary administration of certain drugs that currently require administration by injection, such as GLP-1. Pulmonary administration provides convenience for the patient and we believe a major advantage of drugs inhaled as Technosphere formulations is that they have been shown to be absorbed very rapidly into the arterial circulation, essentially mimicking intra-arterial administration. MannKind is also developing other inhalation technologies, including an innovative line of patient-focused, breath-activated, dry powder inhalers and inhalation profiling to characterize patient inhalation.
Company Growth (employees)
Type
Public
HQ
Santa Clarita, US
Founded
1991
Size (employees)
153 (est)-20%
MannKind Corporation was founded in 1991 and is headquartered in Santa Clarita, US

Key People/Management at MannKind Corporation

Michael Castagna

Michael Castagna

Chief Executive Officer
Steven Binder

Steven Binder

Chief Financial Officer
David B. Thomson

David B. Thomson

Corporate Vice President, General Counsel and Corporate Secretary
Patrick McCauley

Patrick McCauley

Chief Commercial Officer
Stuart A. Tross

Stuart A. Tross

Chief People Officer

MannKind Corporation Office Locations

MannKind Corporation has an office in Santa Clarita
Santa Clarita, US (HQ)
300 25134 Rye Canyon Loop

MannKind Corporation Financials and Metrics

MannKind Corporation Financials

MannKind Corporation's revenue was reported to be $3 m in Q1, 2017
USD

Revenue (Q1, 2017)

3 m

Gross profit (Q1, 2017)

461 k

Gross profit margin (Q1, 2017), %

15%

Net income (Q1, 2017)

(16.3 m)

EBIT (Q1, 2017)

(19.6 m)

Market capitalization (20-Oct-2017)

410.4 m

Cash (31-Mar-2017)

48 m
MannKind Corporation's current market capitalization is $410.4 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

3.2 m35 k174.8 m

Revenue growth, %

(99%)(100%)

Cost of goods sold

17.1 m

Gross profit

157.6 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

162.4 m3 m

Cost of goods sold

4.3 m2.5 m

Gross profit

158 m461 k

Gross profit Margin, %

97%15%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

70.8 m120.8 m59.1 m22.9 m

Accounts Receivable

302 k

Inventories

5.5 m20.2 m4 m2.3 m

Current Assets

76.3 m201.2 m76.7 m77.5 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

41.2 m172.5 m120.8 m107.2 m32.9 m27.7 m63.7 m35.5 m48 m

Accounts Receivable

3.1 m438 k

Inventories

16.8 m19.8 m23.4 m2.9 m5.1 m3.7 m

Current Assets

44.9 m193.5 m158.3 m145.8 m71.2 m44.1 m90.8 m48.6 m56.1 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(191.5 m)(198.4 m)(368.4 m)125.7 m

Depreciation and Amortization

4.2 m

Accounts Receivable

(302 k)

Inventories

(965 k)(15 m)13.5 m(2.3 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(73.4 m)(36.5 m)(30.7 m)(28.9 m)(31.9 m)(24.9 m)(30 m)126.5 m(16.3 m)

Accounts Receivable

3.1 m438 k

Inventories

16.8 m19.8 m23.4 m2.9 m5.1 m3.7 m

Accounts Payable

5.1 m17.4 m3.3 m5.2 m4.4 m582 k2.8 m5.1 m1.5 m
USDY, 2017

Revenue/Employee

17.4 k

Financial Leverage

-0.4 x
Show all financial metrics

MannKind Corporation Market Value History

Traffic Overview of MannKind Corporation

MannKind Corporation Online and Social Media Presence

MannKind Corporation Company Life and Culture

You may also be interested in